The latest Market Talks covering Equities. Published exclusively on Dow Jones Newswires throughout the day.

0734 GMT - Advanced Info Service's revenue recovery is likely to persist in 4Q after growing 1.4% in 3Q, CGS-CIMB says as it raises the stock's target price to THB259.00 from THB254.00. It keeps an add rating on the mobile phone operator, expecting core service revenue to keep rising as the reopening of Thailand's economy improves consumers' purchasing power. The brokerage expects core service revenue and Ebitda to expand 4.6% and 4.0%, respectively, in FY 2022, thanks to the recovery of the economy and of tourist arrivals. Shares are 1.3% higher at THB191.00. (ronnie.harui@wsj.com)

0731 GMT - Fresenius joins the long list of companies warning on rising costs as raw-materials, energy and shipping prices increase. In its third-quarter reporting, the healthcare company said it expects the rest of the year to be affected by headwinds from cost inflation, as well as supply-chain constraints. Companies across a wide range of sectors--from plane maker Airbus to car makers and beverage companies have warned about the continued drag from supply-chain issues. Consumer-goods companies Nestle and Unilever also recently said they would increase their prices on the back of rising costs. (cristina.roca@wsj.com; @_cristinaroca)

0724 GMT - Chinese stocks finished the session mixed, dragged by lenders, power producers and property developers. Huaneng Power International retreated 5.9% and China Three Gorges Renewables was 3.0% lower, while China Merchants Bank shed 3.5% and Industrial Bank fell 5.0%. Developers continued on a downtrend amid weak sentiment. China Vanke dropped 3.0% and Seazen Holdings lost 3.7%. China Tourism Group declined 7.8% after slumping 10% on Monday following 3Q results. Among gainers, shipbuilder China CSSC surged 10% and China Shipbuilding Industry advanced 7.3%. The Shanghai Composite Index fell 1.1% to 3505.63, the Shenzhen Composite Index slipped 0.8% and the ChiNext Price Index was 0.2% higher. (clarence.leong@wsj.com)

0713 GMT - Wilmar International's shares look undervalued even as its fundamentals look strong, RHB Research says, noting the stock is trading at 12.3X its forward 2022 price/earnings ratio. In comparison, its China-listed peers--some 90% of Wilmar's earnings come from its China operations--are trading between 32X-37X, the broker says. RHB says Wilmar's food-product segment may benefit from higher sales volumes due to the upcoming festive season, while its feed and industrial business could gain from higher commodity prices. The broker keeps a buy rating and raises target price to S$5.60 from S$4.50. Shares are 1.1% higher at S$4.46. (yongchang.chin@wsj.com)

0706 GMT - Oberoi Realty may benefit from sales bookings during India's festive season, ICICI Securities says, raising the stock's target price to INR944 from INR938 with an unchanged hold rating. The real-estate developer launched its Elysian Tower B in the last week of October and has already sold inventory worth INR7.9 billion within a week of the launch. Oberoi is targeting further launches in 2H FY 2022 across India's Thane and Borivali to coincide with the festive season, and the brokerage expects the company to post at least INR40 billion of sales bookings in FY 2022. Shares are 2.0% higher at INR984.55. (ronnie.harui@wsj.com)

0642 GMT - South Korea's benchmark Kospi rose 1.2% to close at 3013.49, led by electronics, energy and retail stocks. Risk appetite kicked in after Wall Street's gains overnight. Foreign and institutional investors remained net buyers through the session. Index heavyweight Samsung Electronics rose 2.3%, while memory-chip maker SK Hynix gained 0.9%. Energy company SK Innovation jumped 3.8% and battery maker Samsung SDI added 1.1% after its above-consensus 3Q earnings. Retailers Hyundai Department Store and Lotte Himart rose 3.5% and 2.4%, respectively. Meanwhile, pharmaceutical company Green Cross fell 3.9% despite its solid quarterly earnings, amid sluggish contract manufacturing of Covid-19 vaccines.(kwanwoo.jun@wsj.com)

0629 GMT - Chinese property developers are likely to miss their contracted sales targets for the year, CGS-CIMB says. It notes that although October sales grew 4% on month, they fell 22% lower. For developers to hit their 2021 targets, the sector needs to increase both November and December sales by 65% on year, which is unlikely, the broker says. "Despite policy easing ahead, we expect liquidity concerns to continue to weigh on the share prices of developers in the near future," it says. CGS-CIMB maintains a neutral rating on the sector. Its sector picks include China Resources Land, KWG Group and Longfor Group. (yongchang.chin@wsj.com)

0628 GMT - Ganfeng Lithium's supply deal with Tesla over 2022-24 is only a minor positive, as it appears to be a contract renewal and details are lacking, Daiwa Capital says. Ganfeng signed a three-year contract with the electric-car maker in September 2018, so "it should not be a surprise for Ganfeng to continue supplying Tesla," Daiwa says. Ganfeng didn't specify the quantity and price in Monday's new contract, which makes it hard to judge if the lithium producer can get a higher price. Long-term contract prices can be gauged by looking at export data from Jiangxi province, where Ganfeng is based, says Daiwa, which expects the October data to be reported in late November. Ganfeng's H-shares pare gains of as much as 9.3% to trade 2.9% higher at HK$147.80. (clarence.leong@wsj.com)

0624 GMT - Green Cross may post softer-than-expected 2021 earnings due to sluggish contract manufacturing of Covid-19 vaccines, Hanwha Investment & Securities says. The South Korean pharmaceutical company has yet to log any meaningful revenue growth from CEPI, the WHO-led global initiative for the joint purchase of Covid-19 vaccines and their distribution to developing countries, the brokerage notes. Hanwha lowers the stock's target by 25% to KRW360,000 to factor in slow growth for its contract manufacturing of Covid-19 vaccines. But it maintains a buy rating, citing solid growth in other segments, including flu vaccines, in 2H. Shares are 4.1% lower at KRW267,500.(kwanwoo.jun@wsj.com)

0540 GMT - Apollo Tyres faces near-term margins pressures caused by rising commodity prices, Nomura says, as it trims the stock's target price to INR301 from INR307. To help offset these pressures, the tire manufacturer has raised prices by 3%-5% for October/November across its segments, the brokerage notes. Replacement demand for the company's truck tires is expected to post a CAGR of 6%-8% over FY 2022-2024 as operators' profitability has improved following the sharp rise in freight rates. Its stock is presently trading an estimated 5.3 times the EV-to-Ebitda multiple for FY 2023, which is attractive to Nomura; it reiterates the stock's buy rating. The shares are 2.1% higher at INR225.20. (ronnie.harui@wsj.com)

0530 GMT - Australia's S&P/ASX 200 closed 0.6% lower at 7324.3 after the Reserve Bank of Australia said it would stop using yield caps and signaled an earlier start to interest-rate increases. The materials sector was the session's biggest loser, down 2.1%, followed by financials, which finished 1.3% lower. IGO fell 8.4% and Brickworks lost 3.7%. IAG was a drag, closing 7.0% lower after it increased its expectation for FY 2022 net natural perils claim costs in the wake of recent storm events. Fellow general insurers QBE and Suncorp lost 2.4% and 4.2%, respectively. Major banks closed between 0.5% and 2.7% lower, while Beach Energy dropped 3.9% after announcing its CEO Matt Kay had resigned.(alice.uribe@wsj.com)